Lunit (KRX:328130.KQ), a leading provider of AI for cancer diagnostics and therapeutics, announced on May 23 that 12 studies featuring its AI-powered digital pathology solution will be presented at the 2025 American Society of Clinical Oncology...

HALO AI, Indica Labs’ deep-learning add-on for the HALO® image analysis platform, helps users solve image analysis challenges in segmentation, classification, and phenotyping across diverse research areas and use cases. This powerful...

Lunit: A new study published in the Journal for ImmunoTherapy of Cancer (JITC) shows that Lunit's AI-powered biomarker "Lunit SCOPE IO" can predict favorable outcomes of Inflamed Immune Phenotype patients treated with Immune Checkpoint...

Read the latest publication from RareCyte. Journal of Clinical Oncology: Whole-slide biomarker quantitation in 82-patient NSCLC cohort study of acquired resistance to PD-(L)1 ICI therapy Understanding the mechanisms of acquired resistance...

The application, known as iStar, was created by Perelman School of Medicine researchers to give clinicians more insights into gene activities in medical images and, potentially, help them diagnose cancers that might have otherwise been...

Read how Orion™ was used to identify improved prognostic signatures for colorectal cancer patients in this publication from Harvard Medical School. "High-plex immunofluorescence imaging and traditional histology of the same tissue section...